category,datetime,headline,id,image,related,source,summary,url
company,1768406259,"DexCom (DXCM) Releases Preliminary, Unaudited Results for Q4 2025",138112067,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,DXCM,Yahoo,"DexCom, Inc. (NASDAQ:DXCM) is one of the Best Fundamental Stocks to Buy According to Analysts. On January 12, the company released its preliminary, unaudited results for Q4 2025, with total revenue coming at ~$1.260 billion, reflecting an increase of 13% YoY. Notably, the US revenue is projected to be ~$892 million, demonstrating 11% growth compared to [â€¦]",https://finnhub.io/api/news?id=a4799c17d20fb88e8093ed75d2b9135656b492b8ca42af3f6a5a71ac3f1dc3f8
company,1768364814,How Investors May Respond To DexCom (DXCM) Strong 2025 Revenue Beat And 2026 Growth Outlook,138097177,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,DXCM,Yahoo,"DexCom recently reported preliminary, unaudited results showing fourth-quarter 2025 revenue of about US$1.26 billion and full-year 2025 revenue of roughly US$4.66 billion, both rising at double-digit rates from 2024 while reiterating its margin guidance. The company also issued 2026 revenue guidance of US$5.16 billion to US$5.25 billion, tying expected growth to higher sensor volumes, the Stelo rollout, and further international expansion, even as some analysts highlight intensifying...",https://finnhub.io/api/news?id=333b6c49e8a0459ec6c458ffe3e7b3d65e1deb1dac188a6e0604fe946f014619
company,1768350788,Is DexCom (DXCM) Pricing Justified After Recent Multi Year Share Price Weakness,138097178,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,DXCM,Yahoo,"Wondering whether DexCom's current share price lines up with its underlying worth, or if the market is missing something important about this glucose monitoring specialist? DexCom shares last closed at US$70.25, with returns of 0.5% over 7 days, 4.9% over 30 days, 5.6% year to date, but an 11.3% decline over 1 year, a 35.9% decline over 3 years and a 21.4% decline over 5 years, which can change how investors think about both risk and opportunity. Recent coverage of DexCom has focused on its...",https://finnhub.io/api/news?id=88dd7c4da76e4d917452f3d157bd321c7935c3a3d86d3e411a92edf887d59acb
